Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer

Journal of Pathology

Volumn 234, Issue 3, 2014, Pages 302-315

  Otani, Koji ^a,b   Dong, Yujuan ^a   Li, Xiaoxing ^a   Lu, Jing ^a   Zhang, Ning ^a   Xu, Lixia ^a   Go, Minnie Y Y ^a   Ng, Enders K W ^a   Arakawa, Tetsuo ^b   Chan, Francis K L ^a   Sung, Joseph J Y ^a   Yu, Jun ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Gastric cancer; Methylation; Odd skipped related 1 (Osr1); Prognosis; Tumour suppressor

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BETA CATENIN; COMPLEMENTARY DNA; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; DEATH RECEPTOR 5; FAS ANTIGEN; LYMPHOID ENHANCER FACTOR; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; PROTEIN P21; PROTEIN P53; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 7; TRICHOSTATIN A; UNCLASSIFIED DRUG; WNT PROTEIN; OSR1 PROTEIN, HUMAN; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE ARREST; CONTROLLED STUDY; DISEASE MARKER; DNA METHYLATION; DOWN REGULATION; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; ODD SKIPPED RELATED 1 GENE; SIGNAL TRANSDUCTION; STOMACH CANCER; SURVIVAL RATE; T LYMPHOCYTE; TRANSCRIPTION INITIATION; TUMOR SUPPRESSOR GENE; WNT SIGNALING PATHWAY; AGED; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84907946288     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4391     Document Type: Article

References (38)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-2917.
2. Otani K, Li X, ArakawaT, et al. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn 2013; 13: 445-455.
3. Kang GH, Lee HJ, Hwang KS, et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 2003; 163:1551-1556.
4. Kang GH, Lee S, Kim JS, et al. Profile of aberrant CpG island methylation along multistep gastric carcinogenesis. Lab Invest 2003; 83: 519-526.
5. Zhao J, Liang Q, Cheung KF, et al. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells. Cancer 2013; 119: 304-312.
6. KatohM.Molecular cloning and characterization of OSR1 on human chromosome 2p24. Int J Mol Med 2002; 10: 221-225.
7. Wang Q, Lan Y, Cho ES, et al. Odd-skipped related 1 (Odd 1) is an essential regulator of heart and urogenital development. Dev Biol 2005; 288: 582-594.
8. James RG, Kamei CN, Wang Q, et al. Odd-skipped related 1 is required for development of the metanephric kidney and regulates formation and differentiation of kidney precursor cells. Development 2006; 133: 2995-3004.
9. Tena JJ, Neto A, de la Calle-Mustienes E, et al. Odd-skipped genes encode repressors that control kidney development. Dev Biol 2007; 301: 518-531.
10. Rauch TA, Wang Z, Wu X, et al. DNA methylation biomarkers for lung cancer. Tumour Biol 2012; 33: 287-296.
11. Ganesan K, Ivanova T, Wu Y, et al. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res 2008; 68: 4277-4286.
12. Du R, Xia L, Sun S, et al. URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway. J Cell Mol Med 2010; 14: 621-635.
13. Tahara E. Molecular mechanism of stomach carcinogenesis. J Cancer Res Clin Oncol 1993; 119: 265-272.
14. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480.
15. Logan CY, Nusse R. TheWnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20: 781-810.
16. Bhanot P, Brink M, Samos CH, et al. A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature 1996; 382: 225-230.
17. Mao J, Wang J, LiuB, et al. Low-density lipoprotein receptor-related protein-5 binds to Axin and regulates the canonical Wnt signaling pathway. Mol Cell 2001; 7: 801-809.
18. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.
19. Linke SP, ClarkinKC,Wahl GM. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. Cancer Res 1997; 57: 1171-1179.
20. Midgley CA, Owens B, Briscoe CV, et al. Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivo. J Cell Sci 1995; 108: 1843-1848.
21. Huang Q, Raya A, DeJesus P, et al. Identification of p53 regulators by genome-wide functional analysis. Proc Natl Acad Sci U S A 2004; 101: 3456-3461.
22. Kraus C, Liehr T, Hulsken J, et al. Localization of the human beta-catenin gene (CTNNB1) to 3p21: a region implicated in tumor development. Genomics 1994; 23: 272-274.
23. Sasaki Y, Morimoto I, Kusano M, et al. Mutational analysis of the beta-catenin gene in gastric carcinomas. Tumour Biol 2001; 22:123-130.
24. Li J, Mo ML, Chen Z, et al. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer. Cancer Sci 2011; 102: 1815-1821.
25. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-825.
26. He G, Siddik ZH, Huang Z, et al. Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities. Oncogene 2005; 24: 2929-2943.
27. Quelle DE, Ashmun RA, Shurtleff SA, et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559-1571.
28. Musgrove EA, Lee CS, Buckley MF, et al. Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc Natl Acad Sci U S A 1994; 91: 8022-8026.
29. Haupt S, Berger M, Goldberg Z, et al. Apoptosis - the p53 network. J Cell Sci 2003; 116: 4077-4085.
30. Huang P, Senga T, Hamaguchi M. A novel role of phospho-beta-catenin in microtubule regrowth at centrosome. Oncogene 2007; 26: 4357-4371.
31. Bahmanyar S, Kaplan DD, Deluca JG, et al. β-Catenin is a Nek2 substrate involved in centrosome separation. Genes Dev 2008; 22:91-105.
32. Davidson G, Niehrs C. Emerging links between CDK cell cycle regulators and Wnt signaling. Trends Cell Biol 2010; 20: 453-460.
33. Orford K, Orford CC, Byers SW. Exogenous expression of beta-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest. J Cell Biol 1999; 146: 855-868.
34. Olmeda D, Castel S, Vilaro S, et al. Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis. Mol Biol Cell 2003; 14: 2844-2860.
35. Jho EH, Zhang T, Domon C, et al. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002; 22: 1172-1183.
36. Lloyd-Lewis B, Fletcher AG, Dale TC, et al. Toward a quantitative understanding of the Wnt/beta-catenin pathway through simulation and experiment. Wiley Interdiscip Rev Syst Biol Med 2013; 5:391-407.
37. HadjihannasMV, Bernkopf DB, BrucknerM, et al. Cell cycle control of Wnt/beta-catenin signalling by conductin/axin2 through CDC20. EMBO Rep 2012; 13: 347-354.
38. Ehrlich M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome and chromosomal rearrangements. Journal Nutr 2002; 132: 2424S-2429S.